CAPTOZYME, INC.
GAINESVILLE, FL · CIK 0001684924 · Biotech · Acquired
Oxalate-degrading enzyme therapeutic to reduce systemic oxalate levels in severe hyperoxaluria and related conditions
atom.com →- Grants
- $561K
- 1 award
- Sector median: 1
- Raised
- $3.4M
- 1 Form D · Sep 2016
- 121 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Oxalate Reduction by Oral Administration of Oxalate Degrading Enzymes | $560,860 | |
| Private capital raised | Form D · SEC | $3,400,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3310 | ReNewVax Ltd | — | $3.0M |
| 3311 | SYNAPTICURE INC | — | $40M |
| 3312 | Ampersand Health, LLC | — | $7.7M |
| 3313 | CAPTOZYME, INC. | — | $3.4M |
| 3314 | Hope Portal Services, Inc. | — | $250K |
| 3315 | Hemostemix Inc. | — | $132K |
| 3316 | Zag Bio | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- AARON COWLEYDirector · Executive Officer
- HELENA COWLEYDirector · Executive Officer
- QING-SHAN LIDirector · Executive Officer
Patents
- High Efficiency Oxalate-degrading Enzymes For Degradation Of Insoluble And Soluble Oxalategranted
- High Efficiency Oxalate-degrading Enzymes For Degradation Of Insoluble And Soluble Oxalateapplication
- Methods And Compositions For Treating Oxalate-related Conditionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.